相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design
Tao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties
Hao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Scaffold Hopping-Driven Optimization of 4-(Quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-ones as Novel Tubulin Inhibitors
Li Jiang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
The UDP/P2y6 axis promotes lung metastasis of melanoma by remodeling the premetastatic niche
Juliang Qin et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Kinsie E. Arnst et al.
MEDICINAL RESEARCH REVIEWS (2019)
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy
Kinsie E. Arnst et al.
MOLECULAR PHARMACOLOGY (2019)
Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment
Tzlil Gener Lahav et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
Kashif Haider et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
X-ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors
Kinsie E. Arnst et al.
ACS CHEMICAL BIOLOGY (2019)
Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939
Martine Humbert et al.
BLOOD (2019)
QSAR modeling in ecotoxicological risk assessment: application to the prediction of acute contact toxicity of pesticides on bees (Apis mellifera L.)
Mabrouk Hamadache et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2018)
SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines
Wei Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
Souvik Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design
Oskia Bueno et al.
SCIENTIFIC REPORTS (2018)
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
Bar Ben Baruch et al.
Oncotarget (2018)
CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells
Daniel Wicklein et al.
SCIENTIFIC REPORTS (2018)
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
Darcy Bates et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091
Maria-Dolores Canela et al.
ONCOTARGET (2017)
In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting Agents
Mu-Tian Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Combined molecular docking and QSAR study of fused heterocyclic herbicide inhibitors of D1 protein in photosystem II of plants
Simona Funar-Timofei et al.
MOLECULAR DIVERSITY (2017)
Mechanism of microtubule stabilization by taccalonolide AJ
Yuxi Wang et al.
NATURE COMMUNICATIONS (2017)
3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7
Sarfaraz Alam et al.
SCIENTIFIC REPORTS (2017)
New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer
Ying Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Pre-metastatic niches: organ-specific homes for metastases
Hector Peinado et al.
NATURE REVIEWS CANCER (2017)
Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
Yuxi Wang et al.
FEBS JOURNAL (2016)
Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
Xiaoxin Wu et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105
Darcy Bates et al.
CANCER BIOLOGY & THERAPY (2016)
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
Maria Jesus Perez-Perez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
Souvik Banerjee et al.
MOLECULES (2016)
The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents
Xin Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Optimization of N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines as tubulin polymerization inhibitors
Sheng-Biao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Ya-Ting Ji et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Design, Synthesis and Biological Evaluation of Novel 5H-Chromenopyridines as Potential Anti-Cancer Agents
Souvik Banerjee et al.
MOLECULES (2015)
Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
Daniele Fanale et al.
ANALYTICAL CELLULAR PATHOLOGY (2015)
Two-and Three-dimensional Rings in Drugs
Matteo Aldeghi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels
Katharina Mahal et al.
CHEMMEDCHEM (2014)
Recent developments in tubulin polymerization inhibitors: An overview
Ramandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site
Xiao-Feng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Prediction of antiprion activity of therapeutic agents with structure-activity models
Katja Venko et al.
MOLECULAR DIVERSITY (2014)
Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential
Aleem Gangjee et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
N-Aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: A novel class of antitumor agents targeting the colchicine site on tubulin
Xiao-Feng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Fragment-based strategy for structural optimization in combination with 3D-QSAR
Haoliang Yuan et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Discovery of 4-Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitor with Potent Antiproliferative Properties
Min Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Maslinic acid and its in vitro anti-neoplastic effects
Shailendra Kapoor
NATURAL PRODUCT RESEARCH (2013)
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
Andrea E. Prota et al.
SCIENCE (2013)
Quantitative structure-activity relationship analysis of perfluoroiso-propyldinitrobenzene derivatives known as photosystem II electron transfer inhibitors
Mehmet Sayim Karacan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2012)
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
Jun Ling et al.
CANCER LETTERS (2012)
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F. Grossmann et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Formulation and Characterization of Polyester/Polycarbonate Nanoparticles for Delivery of a Novel Microtubule Destabilizing Agent
Vaibhav Mundra et al.
PHARMACEUTICAL RESEARCH (2012)
Novel Tubulin Polymerization Inhibitors Overcome Multidrug Resistance and Reduce Melanoma Lung Metastasis
Zhao Wang et al.
PHARMACEUTICAL RESEARCH (2012)
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Yan Lu et al.
PHARMACEUTICAL RESEARCH (2012)
New insights into mechanisms of resistance to microtubule inhibitors
Anutosh Ganguly et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
Dietmar W. Siemann
CANCER TREATMENT REVIEWS (2011)
A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment
Ralph P. Mason et al.
INTEGRATIVE BIOLOGY (2011)
QSAR model toward the rational design of new agrochemical fungicides with a defined resistance risk using substructural descriptors
Alejandro Speck-Planche et al.
MOLECULAR DIVERSITY (2011)
Drugs That Target Dynamic Microtubules: A New Molecular Perspective
Richard A. Stanton et al.
MEDICINAL RESEARCH REVIEWS (2011)
Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents
Ishwaria M. Subbiah et al.
ONCOLOGIST (2011)
Quantitative Structure-Activity Relationship Analysis of 4(3H)-Quinazolone Derivatives as Tyrosine Kinase Inhibitors by Multiple Linear Regression
Vikas Srivastava et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance
Aleem Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Vinblastine Induces Acute, Cell Cycle Phase-Independent Apoptosis in Some Leukemias and Lymphomas and Can Induce Acute Apoptosis in Others when Mcl-1 Is Suppressed
Bethany L. Salerni et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Management of advanced breast cancer with the epothilone B analog, ixabepilone
William Gradishar
Drug Design Development and Therapy (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Quantitative Structure-Property Relationship (Correlation Analysis) of Phosphonic Acid-Based Chelates in Design of MRI Contrast Agent
Anjani K. Tiwari et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?
Timothy J. Ritchie et al.
DRUG DISCOVERY TODAY (2009)
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
Dietmar W. Siemann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration
Nilantha Sirisoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Variations in the colchicine-binding domain provide insight into the structural switch of tubulin
Audrey Dorleans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cell-cycle control in the face of damage - a matter of life or death
Paul R. Clarke et al.
TRENDS IN CELL BIOLOGY (2009)
Design, Structure Activity Relationships and X-Ray Co-Crystallography of Non-Steroidal LXR Agonists
A. Edwards et al.
CURRENT MEDICINAL CHEMISTRY (2008)
分享论文
